Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics.SummaryDifference0.2%

- Check39 days agoChange DetectedRelated topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the study record's metadata. This changes how the page is categorized and surfaced in topic-based searches.SummaryDifference0.2%

- Check46 days agoChange DetectedAdded Revision: v3.4.2; removed prior notices including the lapse in government funding notice and Revision: v3.4.1.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded a government funding lapse notice at the top of the page informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.